Gawrieh S - Search Results

1

Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study.

Corey KE, Gawrieh S, deLemos AS, Zheng H, Scanga AE, Haglund JW, Sanchez J, Danford CJ, Comerford M, Bossi K, Munir S, Chalasani N, Wattacheril J. Corey KE, et al. Among authors: gawrieh s. World J Hepatol. 2017 Mar 8;9(7):385-390. doi: 10.4254/wjh.v9.i7.385. World J Hepatol. 2017. PMID: 28321274 Free PMC article.

2

Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.

Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K. Charlton M, et al. Among authors: gawrieh s. Hepatology. 2008 Feb;47(2):484-92. doi: 10.1002/hep.22063. Hepatology. 2008. PMID: 18220286 Free PMC article.

3

NAFLD fibrosis score: is it ready for wider use in clinical practice and for clinical trials?

Gawrieh S, Chalasani N. Gawrieh S, et al. Gastroenterology. 2013 Oct;145(4):717-9. doi: 10.1053/j.gastro.2013.08.025. Epub 2013 Aug 22. Gastroenterology. 2013. PMID: 23973850 Free PMC article. No abstract available.

4

NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.

Corey KE, Vuppalanchi R, Wilson LA, Cummings OW, Chalasani N; NASH CRN. Corey KE, et al. Aliment Pharmacol Ther. 2015 Feb;41(3):301-9. doi: 10.1111/apt.13035. Epub 2014 Nov 28. Aliment Pharmacol Ther. 2015. PMID: 25429853 Free PMC article. Clinical Trial.

5

Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies.

Vanderbeck S, Bockhorst J, Kleiner D, Komorowski R, Chalasani N, Gawrieh S. Vanderbeck S, et al. Among authors: gawrieh s. Hum Pathol. 2015 May;46(5):767-75. doi: 10.1016/j.humpath.2015.01.019. Epub 2015 Feb 19. Hum Pathol. 2015. PMID: 25776030 Free PMC article.

6

Pharmacotherapy for Nonalcoholic Fatty Liver Disease.

Gawrieh S, Chalasani N. Gawrieh S, et al. Semin Liver Dis. 2015 Aug;35(3):338-48. doi: 10.1055/s-0035-1562951. Epub 2015 Sep 17. Semin Liver Dis. 2015. PMID: 26378648 Free PMC article. Review.

7

Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans.

Liu W, Anstee QM, Wang X, Gawrieh S, Gamazon ER, Athinarayanan S, Liu YL, Darlay R, Cordell HJ, Daly AK, Day CP, Chalasani N. Liu W, et al. Among authors: gawrieh s. Aging (Albany NY). 2016 Oct 13;9(1):26-40. doi: 10.18632/aging.101067. Aging (Albany NY). 2016. PMID: 27744419 Free PMC article.

8

Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Gawrieh S, Chalasani N. Gawrieh S, et al. Clin Liver Dis. 2018 Feb;22(1):189-199. doi: 10.1016/j.cld.2017.08.013. Epub 2017 Oct 10. Clin Liver Dis. 2018. PMID: 29128056 Free article. Review.

9

Automated assessment of steatosis in murine fatty liver.

Sethunath D, Morusu S, Tuceryan M, Cummings OW, Zhang H, Yin XM, Vanderbeck S, Chalasani N, Gawrieh S. Sethunath D, et al. Among authors: gawrieh s. PLoS One. 2018 May 10;13(5):e0197242. doi: 10.1371/journal.pone.0197242. eCollection 2018. PLoS One. 2018. PMID: 29746543 Free PMC article.

10

Vitamin E Improves Transplant-Free Survival and Hepatic Decompensation Among Patients With Nonalcoholic Steatohepatitis and Advanced Fibrosis.

Vilar-Gomez E, Vuppalanchi R, Gawrieh S, Ghabril M, Saxena R, Cummings OW, Chalasani N. Vilar-Gomez E, et al. Among authors: gawrieh s. Hepatology. 2020 Feb;71(2):495-509. doi: 10.1002/hep.30368. Epub 2019 Mar 6. Hepatology. 2020. PMID: 30506586 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters